Viewing Study NCT01882803


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2025-12-30 @ 6:26 AM
Study NCT ID: NCT01882803
Status: COMPLETED
Last Update Posted: 2023-09-07
First Post: 2013-05-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma
Sponsor: SecuraBio
Organization: